The board of directors of ADDvise Group has adopted long term financial targets. The strategy to focus on high revenue growth based on a combination of acquisitions and organic growth remains. Profitable revenue growth combined with reduced net debt to EBITDA is an overall target. Given time dividend to ADDvise Group’s shareholders will be added.
ADDvise Group’s long term financial targets is not to be mistaken for an annual forecast. The financial targets should be seen as an ambition from the board and CEO. The targets will be achieved both by acquisitions and organic growth. The targets are categorized within four areas: growth, profitability, capital structure and dividend.
ADDvise Group’s long term financial targets as of September 11th 2017 are:
Revenue growth: Annual growth in revenue shall exceed 20%. Growth will be both acquired and organic.
Profitability: EBITDA-margin shall reach 10%
Capital structure: Net interest-bearing debt in relation to EBITDA shall not exceed 3,0 times.
Dividend: 25 % of previous year EBT, excluding revaluation of pending earn outs, shall constitute shareholders’ dividend.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on September 11th, 2017 at 09:00 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.